Multi-Level and Intersectional Stigma Experienced by Black Transgender Women in Chicago: a Qualitative Study to Inform Sociostructural Interventions for Reducing Stigma and Improving Health Outcomes.

Black transgender women HIV Social ecological model Stigma

Journal

Journal of racial and ethnic health disparities
ISSN: 2196-8837
Titre abrégé: J Racial Ethn Health Disparities
Pays: Switzerland
ID NLM: 101628476

Informations de publication

Date de publication:
13 Nov 2023
Historique:
received: 11 09 2023
accepted: 24 10 2023
revised: 20 10 2023
medline: 14 11 2023
pubmed: 14 11 2023
entrez: 13 11 2023
Statut: aheadofprint

Résumé

Stigma contributes to health disparities including increased HIV vulnerability among minority communities. Black transgender women experience multiple forms of stigma (e.g., anticipated, experienced), which can result in poor HIV-related outcomes. We utilized an adapted social ecological model (ASEM) to better understand the levels at which stigma is encountered and its impact on lived experience, particularly related to making healthcare decisions. Semi-structured interviews and two focus groups (n = 38) were conducted with Black transgender women and Black transfeminine individuals in Chicago from 2016 to 2017. Participants were asked about discrimination in the community, healthcare experiences, and their thoughts and decision-making process with their healthcare provider regarding HIV pre-exposure prophylaxis. We conducted thematic analysis and organized our findings based on the levels of the ASEM: individual, interpersonal, organizational, community, and structural. Participants experienced and anticipated stigma at each ASEM level. Stigma was not experienced in isolation: stigma experienced at one level caused anticipated stigma at other levels and internalized stigma leading to negative self-image. In each case, stigma adversely impacted health outcomes (e.g., medication nonadherence, disengagement from care). Stigma within healthcare settings, medication-related stigma, and stigma directed at appearance and identity are particularly detrimental to shared decision-making with a healthcare provider. Recognizing and valuing Black transgender women's experience with stigma are essential for developing social and structural interventions that may work collaboratively across multiple levels of lived experience to reduce stigma and healthcare disparities faced by Black transgender women.

Sections du résumé

BACKGROUND BACKGROUND
Stigma contributes to health disparities including increased HIV vulnerability among minority communities. Black transgender women experience multiple forms of stigma (e.g., anticipated, experienced), which can result in poor HIV-related outcomes. We utilized an adapted social ecological model (ASEM) to better understand the levels at which stigma is encountered and its impact on lived experience, particularly related to making healthcare decisions.
METHODS METHODS
Semi-structured interviews and two focus groups (n = 38) were conducted with Black transgender women and Black transfeminine individuals in Chicago from 2016 to 2017. Participants were asked about discrimination in the community, healthcare experiences, and their thoughts and decision-making process with their healthcare provider regarding HIV pre-exposure prophylaxis. We conducted thematic analysis and organized our findings based on the levels of the ASEM: individual, interpersonal, organizational, community, and structural.
RESULTS RESULTS
Participants experienced and anticipated stigma at each ASEM level. Stigma was not experienced in isolation: stigma experienced at one level caused anticipated stigma at other levels and internalized stigma leading to negative self-image. In each case, stigma adversely impacted health outcomes (e.g., medication nonadherence, disengagement from care). Stigma within healthcare settings, medication-related stigma, and stigma directed at appearance and identity are particularly detrimental to shared decision-making with a healthcare provider.
CONCLUSIONS CONCLUSIONS
Recognizing and valuing Black transgender women's experience with stigma are essential for developing social and structural interventions that may work collaboratively across multiple levels of lived experience to reduce stigma and healthcare disparities faced by Black transgender women.

Identifiants

pubmed: 37957538
doi: 10.1007/s40615-023-01853-6
pii: 10.1007/s40615-023-01853-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. W. Montague Cobb-NMA Health Institute.

Références

Fauci AS, et al. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321(9):844–5.
pubmed: 30730529 doi: 10.1001/jama.2019.1343
Goffman E. Stigma: notes on the management of spoiled identity. Simon and Schuster; 1963.
Becasen JSD, Christa L, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109(1):e1–8. https://doi.org/10.2105/AJPH.2018.304727 .
National Academies of Sciences, E. and Medicine. In: Vermund SH, Geller AB, Crowley JS, editors. Sexually transmitted infections: adopting a sexual health paradigm. Washington, DC: The National Academies Press; 2021. p. 750.
Boarts JM, et al. Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study. J Behav Med. 2008;31(5):445–51.
pubmed: 18726151 doi: 10.1007/s10865-008-9169-0
Montoy JC, Dow WH, Kaplan BC. Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial. BMJ. 2016;532:h6895.
pubmed: 26786744 doi: 10.1136/bmj.h6895
Dale SK, et al. Microaggressions and discrimination relate to barriers to care among Black women living with HIV. AIDS Patient Care STDs. 2019;33(4):175–83.
pubmed: 30932695 pmcid: 6459277 doi: 10.1089/apc.2018.0258
Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13(482). https://doi.org/10.1186/1471-2458-13-482 .
CDC. The social ecological model. 2020; Available from: https://www.cdc.gov/violenceprevention/publichealthissue/social-ecologicalmodel.html . Accessed 8 Aug 2023.
Turan B, et al. Framing mechanisms linking HIV-related stigma, adherence to treatment, and health outcomes. Am J Public Health. 2017;107(6):863–9.
pubmed: 28426316 pmcid: 5425866 doi: 10.2105/AJPH.2017.303744
Crenshaw K. Demarginalizing the intersection of race and sex: a Black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. University of Chicago Legal Forum; 1989. (1).
Turan JM, et al. Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Med. 2019;17(1):7.
pubmed: 30764816 pmcid: 6376691 doi: 10.1186/s12916-018-1246-9
Shangani S, et al. Stigma and healthcare-seeking practices of men who have sex with men in Western Kenya: a mixed-methods approach for scale validation. AIDS Patient Care STDs. 2018;32(11):477–86.
pubmed: 30398953 pmcid: 6247373 doi: 10.1089/apc.2018.0101
Bogart LM, et al. Perceived discrimination and physical health among HIV-positive Black and Latino men who have sex with men. AIDS Behav. 2013;17(4):1431–41.
pubmed: 23297084 pmcid: 3631464 doi: 10.1007/s10461-012-0397-5
Rueda S, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453.
pubmed: 27412106 pmcid: 4947735 doi: 10.1136/bmjopen-2016-011453
Crockett KB, et al. Neighborhood racial diversity, socioeconomic status, and perceptions of HIV-related discrimination and internalized HIV stigma among women living with HIV in the United States. AIDS Patient Care STDs. 2019;33(6):270–81.
pubmed: 31166786 pmcid: 6588105 doi: 10.1089/apc.2019.0004
Bradford J, et al. Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103(10):1820–9.
pubmed: 23153142 pmcid: 3780721 doi: 10.2105/AJPH.2012.300796
McNulty MC, Acree ME, Kerman J, Williams HHS, Schneider JA. Shared decision making for HIV pre-exposure prophylaxis (PrEP) with black transgender women. Cult Health Sex. 2022;24(8):1033–46. https://doi.org/10.1080/13691058.2021.1909142 .
Rodriguez A, Agardh A, Asamoah BO. Self-reported discrimination in health-care settings based on recognizability as transgender: a cross-sectional study among transgender U.S. citizens. Arch Sex Behav. 2018;47(4):973–85.
pubmed: 28785919 doi: 10.1007/s10508-017-1028-z
Grant JM Mottet L Tanis JE et al. Injustice at every turn: a report of the national transgender discrimination survey. Washington DC: National center for transgender equality: National gay and lesbian task force; 2011. https://transequality.org/sites/default/files/docs/resources/NTDS_Report.pdf . Accessed November 8 2023.
James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality; 2016.
Kota KK, et al. Stigma, discrimination, and mental health outcomes among transgender women with diagnosed HIV infection in the United States, 2015-2018. Public Health Rep. 2023;138(5):771–81.
pubmed: 36129230 doi: 10.1177/00333549221123583
Sherman ADF, et al. Transgender and gender diverse community connection, help-seeking, and mental health among Black transgender women who have survived violence: a mixed-methods analysis. Violence Against Women. 2022;28(3–4):890–921.
pubmed: 34167394 doi: 10.1177/10778012211013892
Brown LA. HIV/AIDS-related stigma and discrimination: a conceptual framework and an agenda for action horizons program. 2002.
Geter A, Herron AR, Sutton MY. HIV-related stigma by healthcare providers in the United States: a systematic review. AIDS Patient Care STDs. 2018;32(10):418–24.
pubmed: 30277814 doi: 10.1089/apc.2018.0114
Brooks RA, et al. Experiences of pre-exposure prophylaxis stigma, social support, and information dissemination among Black and Latina transgender women who are using pre-exposure prophylaxis. Transgend Health. 2019;4(1):188–96.
pubmed: 31482134 pmcid: 6716188 doi: 10.1089/trgh.2019.0014
Godley BA, Adimora AA. Syndemic theory, structural violence and HIV among African-Americans. Curr Opin HIV AIDS. 2020;15(4):250–5. https://doi.org/10.1097/COH.0000000000000634 .
Herbst JH, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12(1):1–17.
pubmed: 17694429 doi: 10.1007/s10461-007-9299-3
Turan B, et al. Association between perceived discrimination in healthcare settings and HIV medication adherence: mediating psychosocial mechanisms. AIDS Behav. 2017;21(12):3431–9.
pubmed: 29081045 pmcid: 5705383 doi: 10.1007/s10461-017-1957-5
Peek MEL, Fanny Y, Williams HS, Xu LJ, McNulty MC, Acree ME, Schneider JA. Development of a conceptual framework for understanding shared decision making among African-American LGBT patients and their clinicians. J Gen Intern Med. 2016;31:677–87.
pubmed: 27008649 pmcid: 4870421 doi: 10.1007/s11606-016-3616-3
Nordmarken S, Kelly R. In: Harvey VL, Heinz Housel T, editors. Limiting transgender health: administrative violence and microaggressions in health care systems, in Health care disparities and the LGBT population. Plymouth, United Kingdom.: Lexington Books; 2014. p. 143–66.
Hudson KD. (Un)doing transmisogynist stigma in health care settings: experiences of ten transgender women of color. J Progress Hum Serv. 2018;30(1):69–87.
doi: 10.1080/10428232.2017.1412768
Howard SD, et al. Healthcare experiences of transgender people of color. J Gen Intern Med. 2019;34(10):2068–74.
pubmed: 31385209 pmcid: 6816758 doi: 10.1007/s11606-019-05179-0
Quinn K, Bowleg L, Dickson-Gomez J. “The fear of being Black plus the fear of being gay”: the effects of intersectional stigma on PrEP use among young Black gay, bisexual, and other men who have sex with men. Soc Sci Med. 2019;232:86–93.
pubmed: 31075752 pmcid: 6588433 doi: 10.1016/j.socscimed.2019.04.042
Chen YT, et al. COVID-19-related stressors, sex behaviors, and HIV status neutral care among Black men who have sex with men and transgender women in Chicago, USA. J Acquir Immune Defic Syndr. 2021;88(3):261–71.
pubmed: 34310447 pmcid: 8518204 doi: 10.1097/QAI.0000000000002770
Kloer C, Lewis HC, Rezak K. Delays in gender affirming healthcare due to COVID-19 are mitigated by expansion of telemedicine. Am J Surg. 2023;225(2):367–73.
pubmed: 36182596 doi: 10.1016/j.amjsurg.2022.09.036
Eaton LA, et al. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.
pubmed: 28108878 pmcid: 5926187 doi: 10.1007/s10461-017-1690-0
Rael CT, et al. Barriers and facilitators to oral PrEP use among transgender women in New York City. AIDS Behav. 2018;22(11):3627–36.
pubmed: 29589137 pmcid: 6160363 doi: 10.1007/s10461-018-2102-9
Krug EG, et al. The world report on violence and health. Lancet. 2002;360(9339):1083–8.
pubmed: 12384003 doi: 10.1016/S0140-6736(02)11133-0
QSR International Pty Ltd. NVivo qualitative data analysis [software]. 2017 Vers. 11.4.1 QSR International Pty Ltd. Available at: https://support.qsrinternational.com/nvivo/s/ .
Kemnitz R, et al. Manifestations of HIV stigma and their impact on retention in care for people transitioning from prisons to communities. Health Justice. 2017;5(1):7.
pubmed: 28589252 pmcid: 5461223 doi: 10.1186/s40352-017-0054-1
White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31.
pubmed: 26599625 pmcid: 4689648 doi: 10.1016/j.socscimed.2015.11.010
Office of Disease Prevention and Health Promotion. Healthy People 2030. 2023; Available from: https://health.gov/healthypeople/objectives-and-data/social-determinants-health . Accessed 8 Aug 2023.
Hatzenbuehler ML, Link BG. Introduction to the special issue on structural stigma and health. Soc Sci Med. 2014;103:1–6.
pubmed: 24445152 doi: 10.1016/j.socscimed.2013.12.017
Ogunbajo A, et al. Multilevel barriers to HIV PrEP uptake and adherence among Black and Hispanic/Latinx transgender women in Southern California. AIDS Behav. 2021;25(7):2301–15.
pubmed: 33515132 pmcid: 7845787 doi: 10.1007/s10461-021-03159-2
Wilson PA, et al. Contributions of qualitative research in informing HIV/AIDS interventions targeting Black MSM in the United States. J Sex Res. 2016;53(6):642–54.
pubmed: 26241373 doi: 10.1080/00224499.2015.1016139
Ding JM, et al. A model for improving health care quality for transgender and gender nonconforming patients. Jt Comm J Qual Patient Saf. 2020;46(1):37–43.
pubmed: 31708472
Reisner SL, Radix A, Deutsch MB. Integrated and gender-affirming transgender clinical care and research. J Acquir Immune Defic Syndr. 2016;72 Suppl 3(Suppl 3):S235–42.
pubmed: 27429189 doi: 10.1097/QAI.0000000000001088
Reback CJ, Kisler KA, Fletcher JB. A novel adaptation of peer health navigation and contingency management for advancement along the HIV care continuum among transgender women of color. AIDS Behav. 2021;25(1):40–51.
pubmed: 31187355 pmcid: 6904539 doi: 10.1007/s10461-019-02554-0
Rendina HJ, et al. Measuring experiences of minority stress for transgender women: adaptation and evaluation of internalized and anticipated transgender stigma scales. Transgend Health. 2020;5(1):42–9.
pubmed: 32322687 pmcid: 7173692 doi: 10.1089/trgh.2019.0059

Auteurs

Jared Kerman (J)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

Russell Brewer (R)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

Anna Hotton (A)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

Rey Flores (R)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

Samantha A Devlin (SA)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

Eleanor E Friedman (EE)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

John A Schneider (JA)

Chicago Center for HIV Elimination, Chicago, IL, USA.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA.

Moira C McNulty (MC)

Chicago Center for HIV Elimination, Chicago, IL, USA. moira.mcnulty@bsd.uchicago.edu.
Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA. moira.mcnulty@bsd.uchicago.edu.

Classifications MeSH